Healthcare compliance analytics company achieves highest score for Patient Privacy Monitoring and Drug Diversion Surveillance Solutions
Protenus, the leading healthcare compliance analytics platform empowering healthcare to eliminate risk, received the highest overall performance score for both its patient privacy monitoring and drug diversion surveillance solutions in the recently published 2023 Best in KLAS: Software & Services report. Privacy violations and clinical drug diversion create huge risks for hospitals’ and health systems’ reputations and finances and the safety of their patients, workforces, and communities at-large. KLAS’ annual report, based on survey responses from hospital customers, grades vendors on their ability to consistently deliver guidance, analytics, and insight that helps their customers identify and prevent privacy data breaches and drug diversion.
According to KLAS CEO Adam Gale, “The 2023 Best in KLAS report highlights the top-performing healthcare IT solutions as determined by extensive evaluations and conversations with thousands of healthcare providers. These distinguished winners have demonstrated exceptional dedication to improving and innovating the industry, and their efforts are recognized through their inclusion in this report.”
Hospital stakeholder input offers commentary such as, “I tell folks to save themselves all the trouble by just starting with Protenus and getting on with things. Protenus will implement their software faster, better, sooner, and with a more robust interface than anyone else will. The competition has a heck (sic) of a long way to go to catch up to Protenus. Protenus is probably the best-kept secret. I can’t say enough great things about Protenus. I really can’t think of anything that they could do differently that would be better. I think Protenus is on the perfect track right now.” – KLAS Survey Respondent, March 2022.
Protenus CEO and Co-Founder Nick Culbertson remarked, “Our AI-driven solutions help our customers take a preventive approach to patient privacy breaches and drug diversion, which is critical for mitigating risk. We are truly appreciative of the time our customers take to respond to KLAS inquiries, providing thoughtful feedback so we can continue to deliver high-quality support and offer leading solutions to top healthcare organizations nationwide. We are committed to our customer community and rely on their partnership and feedback as we work together to strengthen healthcare compliance and reduce risk within their organizations.”
